Reversion-inducing cysteine-rich protein with kazal motifs and matrix metalloproteinase-9 are prognostic markers in skull base chordomas

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Neurosurgical review

• Publication date

  2010-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s10143-009-0228-yPMID 19862564
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Expression of matrix metalloproteinases-1, -2, and -9; tissue inhibitors of matrix metalloproteinases-1 and -2; cathepsin B; urokinase plasminogen activator; and plasminogen activator inhibitor, type I in skull base chordoma.

  2008influential reference
• RECK expression in osteosarcoma: correlation with matrix metalloproteinases activation and tumor invasiveness

  2007cited by this paper
• Low expression of reversion-inducing cysteine-rich protein with Kazal motifs (RECK) indicates a shorter survival after resection in patients with adenocarcinoma of the lung.

  2007cited by this paper
• Analysis of immunohistochemical expression of p53 and the proliferation marker Ki-67 antigen in skull base chordomas: relationships between their expression and prognosis

  2007cited by this paper
• RECK—a newly discovered inhibitor of metastasis with prognostic significance in multiple forms of cancer

  2007cited by this paper
• Decreased RECK expression indicating proteolytic imbalance in prostate cancer is associated with higher tumor aggressiveness and risk of prostate-specific antigen relapse after radical prostatectomy.

  2007cited by this paper
• Matrix metalloproteinase-2 and-9 expression in astrocytic tumors

  2006influential reference
• Expression and quantitative analysis of matrix metalloproteinase-2 and-9 in human gliomas

  2006cited by this paper
• Expression of reversion-inducing-cysteine-rich protein with Kazal motifs (RECK) as a prognostic indicator in gastric cancer.

  2006cited by this paper
• Cadherins and Catenins in Clival Chordomas: Correlation of Expression With Tumor Aggressiveness

  2005cited by this paper
• Evaluation of a new concept for the management of skull base chordomas and chondrosarcomas.

  2005cited by this paper
• Matrix metalloproteinase-9 secretion by human pituitary adenomas detected by cell immunoblot analysis

  2005cited by this paper
• Prognostic Value of MIB-1, E-Cadherin, and CD44 in Pediatric Chordomas

  2005cited by this paper
• Matrix metalloproteinase 2 and 9 expression correlated with cavernous sinus invasion of pituitary adenomas.

  2005influential reference
• Matrix Metalloproteinase-2 and Matrix Metalloproteinase-9 Expressions Correlate with the Recurrence of Intracranial Meningiomas

  2004cited by this paper
• Expression of matrix metalloproteinase (MMP)-1, MMP-2, MMP-9, cathepsin B, and urokinase plasminogen activator in non-skull base chordoma.

  2004cited by this paper
• Expression of Matrix Metalloproteinases and Their Inhibitors in Medulloblastomas and Their Prognostic Relevance

  2004influential reference
• Expression of serine proteases and metalloproteinases in human pituitary adenomas and anterior pituitary lobe tissue

  2003influential reference
• RECK expression in pancreatic cancer: its correlation with lower invasiveness and better prognosis.

  2003cited by this paper
• Matrix metalloproteinase inhibitor reversion‐inducing cysteine‐rich protein with Kazal motifs

  2003cited by this paper
• Chordoma of the skull base: predictors of tumor recurrence.

  2003cited by this paper
• Expression of Growth Factors and Structural Proteins in Chordomas: Basic Fibroblast Growth Factor, Transforming Growth Factor &agr;, and Fibronectin Are Correlated with Recurrence

  2002cited by this paper
• Apoptotic and proliferative markers in chordomas: a study of 26 tumors.

  2002cited by this paper
• RECKing MMP function: implications for cancer development.

  2002cited by this paper
• Are Nonfunctioning Pituitary Adenomas Extending into the Cavernous Sinus Aggressive and/or Invasive?

  2001cited by this paper
• Expression of matrix metalloproteinases in a series of 12 meningiomas.

  2001cited by this paper
• The Membrane-Anchored MMP Inhibitor RECK Is a Key Regulator of Extracellular Matrix Integrity and Angiogenesis

  2001cited by this paper
• Matrix metalloproteinase-9 (gelatinase B) is selectively elevated in CSF during relapses and stable phases of multiple sclerosis.

  1998cited by this paper
• Chordomas and chondrosarcomas of the cranial base: results and follow-up of 60 patients.

  1995cited by this paper

• Matrix Metalloproteinase‐13 Is an Unfavorable Prognostic Factor in Chordoma by Digesting Growth Inhibitory Collagens

  2026influential citation
• Role of extracellular matrix in chordoma progression and therapeutic resistance.

  2025cites this paper
• Prognostic molecular biomarkers in chordomas: A systematic review and identification of clinically usable biomarker panels

  2022cites this paper
• Prognostic Factors in Skull Base Chordoma: A Systematic Literature Review and Meta-Analysis.

  2018cites this paper
• Letter: Factors Predicting Recurrence after Resection of Clival Chordoma Using Variable Surgical Approaches and Radiation Modalities.

  2017cites this paper
• Reversion-Inducing Cysteine-Rich Protein With Kazal Motifs (RECK) In Angiogenesis Of Microvessels In Glioblastoma

  2017cites this paper
• Role of the ECM in notochord formation, function and disease

  2017cites this paper
• Potential Role of Reversion-Inducing Cysteine-Rich Protein with Kazal Motifs (RECK) in Regulation of Matrix Metalloproteinases (MMPs) Expression in Periodontal Diseases

  2016cites this paper
• Letter: Factors Predicting Recurrence after Resection of Clival Chordoma Using Variable Surgical Approaches and Radiation Modalities

  2015cites this paper
• Chordoma: the entity.

  2014cites this paper
• Expression of RECK in endothelial cells of glioma: comparison with CD34 and VEGF expressions

  2012cites this paper
• Intradural chordoma of the Meckel's cave: A challenging differential diagnosis

  2012cites this paper
• RECKing MMP: relevance of reversion-inducing cysteine-rich protein with kazal motifs as a prognostic marker and therapeutic target for cancer (a review).

  2012cites this paper
• Expression of Ezrin, MMP-9, and COX-2 in 50 Chordoma Specimens: A Clinical and Immunohistochemical Analysis

  2012cites this paper
• Comparison of manual and digital microvascular density counting of RECK expression in glioma

  2012cites this paper
• Reversion-inducing cysteine-rich protein with Kazal motifs interferes with epidermal growth factor receptor signaling

  2011cites this paper